GOVX - GeoVax Labs, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

GeoVax Labs, Inc.

1900 Lake Park Drive
Suite 380
Smyrna, GA 30080
United States

Full Time Employees7

Key Executives

Dr. Robert T. McNally Ph.D.Pres, Chief Exec. Officer & Director167.82kN/A69
Dr. Harriet Latham Robinson Ph.D.Co-Founder, Chief Scientific Officer Emeritus & DirectorN/AN/A79
Mr. Mark W. Reynolds CPACFO & Corp. Sec.240.33kN/A55
Dr. Farshad Guirakhoo Ph.D.Chief Scientific Officer271.57kN/A64
Mr. Donald G. HildebrandFounder, Chairman Emeritus and ConsultantN/AN/A76
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines against infectious diseases and cancer using its novel vaccine platform in the United States. It is developing various vaccines that are in human clinical trials, and preclinical research and development phases, including vaccines against human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for chronic Hepatitis B infections and cancers. The company has collaboration and partnership agreements with National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the HIV Vaccines Trial Network, Centers for Disease Control and Prevention, United States Army Research Institute of Infectious Disease, Emory University, University of Georgia Research Foundation, University of Pittsburgh, Georgia State University Research Foundation, Peking University, University of Texas Medical Branch, Burnet Institute, American Gene Technologies, Inc., Viamune, Inc., The Scripps Research Institute, and Institute of Human Virology. GeoVax Labs, Inc. was founded in 2001 and is headquartered in Smyrna, Georgia.

Corporate Governance

GeoVax Labs, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.